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INTRODUCTION
Alzheimer's disease is a fatal neurodegenerative disorder originally characterized by three neuropathological features including intracellular neurofibrillary tangles (NFTs) consisting of hyperphosphorylated tau protein 1 , senile plaques formed by aggregated amyloid β peptides (Aβ) 2 and lipid granule accumulations (lipoid granules) in neuroglia. 3, 4 According to the amyloid hypothesis 2 , accumulation of Aβ is the primary influence triggering AD pathogenesis and the rest of the disease process. 5 Aβ aggregates into oligomers, which can be of various sizes, and forms diffuse and neuritic plaques in the brain parenchyma, leading to loss of synapses and neurons. 6, 7 However, molecular mechanisms of how monomeric Aβ peptides are converted to neurotoxic oligomers and further to fibrils rich in cross β-sheet motifs are indeterminate. Alois Alzheimer's originally reported pathologic hallmark of AD; lipoid granules in neuroglia 4 and strong clinical evidence demonstrated in the ensuing years suggest an aberrant lipid homeostasis associated with AD pathology along with peptide and protein centric mechanisms, in part for the following reasons. 3, 8 All APP-cleaving secretases as well as APP are transmembrane proteins, suggesting a direct relationship of amyloid pathology with neuronal membrane lipids. Importantly, growing evidence indicates that amyloidogenic processing of APP occurs in lipid rafts, largely because functionally active pools of BACE1 and γ-secretase are present in these cholesterol-and sphingolipid rich membrane micro domains. 9 It is also known that Aβ exerts its cytotoxic effects, at least partly, by perturbating cellular membranes, potentially through the modulation of the activity of phospholipases, such as PLA2 10 and PLC. 11 On the other hand, lipid species, such as ganglioside GM1 was found to trigger Aβ aggregation. 12 Indeed, a major risk factor for sporadic AD (SAD) is the ε4 allelic variant of the apolipoprotein E (APOE) gene, which encodes a protein in cholesterol metabolism and lipid transport further linking AD pathology to lipids 13 . It is thus clear that there is an interrelating molecular pathology of neuronal lipids, peptides and proteins associated with AD pathology. 8, 14, 15 Therefore, a comprehensive lipidome and peptidome/proteome analysis would provide a basis for further understanding of associated molecular changes in AD pathogenesis.
Advances in lipidomics and peptidomics/proteomics, particularly through the use of electrospray ionization mass spectrometry (ESI-MS), has facilitated an accurate profiling of AD-associated changes in lipids such as cholesterol 16 , plasmalogens 17 , sphingolipids 18 , amyloid peptides 19 and protein species such as apoE4 protein 20 in brain tissue. However, these studies were performed using brain tissue extracts where spatially confined changes are convoluted, restricting the direct correlation of molecular information with amyloid plaques which are scenes of AD pathogenesis. Therefore, advanced chemical imaging techniques are required to characterize disease pathology in situ, such as imaging mass spectrometry (IMS). 21 This technique is suited to probe amyloid plaque-associated molecular pathology in specific brain regions. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] In particular, MALDI-IMS was shown to be a powerful technique to probe amyloid plaque-associated Aβ isoforms and neuronal lipids in transgenic mice and postmortem human AD brains. 23, [27] [28] [29] [30] [31] Although the vast majority of AD cases are classified as late-onset SAD, rare but highly penetrant autosomal mutations in genes encoding APP and presenilin 1 and presenilin 2, the catalytic components of the γ-secretase, result in early-onset familial AD (FAD) 32 , sharing certain pathological characteristics with SAD. Therefore, transgenic animal models of AD can serve as model systems for more thorough investigations of the aggregation mechanisms, cell signaling and metabolic pathways in vivo. For example, the mouse model (tgArcSwe), carrying both the Arctic (E693G) and the Swedish (K670M/N671L) mutation, displays extensive Aβ deposition with an early onset age of 5-6 months 33 , and is therefore a well-suited model system to study Aβ plaque pathology.
In this communication, we attempted to shed a light on the molecular pathology of individual hippocampal Aβ plaques in 18 month-old tgArcSwe mice, which can give insight into the pathophysiological processes leading to disease states in AD. We utilized multimodal MALDI-IMS analysis on the same tissue sections to sketch a high-throughput molecular architecture of individual amyloid plaques. Subsequent high-spatial resolution (10μm) dual polarity lipid and peptide/protein MALDI-IMS analysis on the same regions of single tissue sections allowed correlation of the ion images of lipids including sphingolipids, phospholipids, lysophospholipids with multiple amyloid β isoforms at cellular levels in specific brain regions such as hippocampus of tgArcSwe, where extensive amyloid plaque accumulations were observed.
EXPERIMENTAL SECTION

METHODS
Chemicals and Reagents. All chemicals for matrix and solvent preparation were pro-analysis grade and obtained from Sigma-Aldrich (St. Louis, MO), unless otherwise specified.
TissueTek optimal cutting temperature (OCT) compound was purchased from Sakura Finetek (AJ Alphen aan den Rijn, the Netherlands). The ddH2O was obtained from a MilliQ purification system (Merck Millipore, Darmstadt, Germany).
Animals, Tissue Sampling and Sectioning.
Transgenic mice (n = 3), 18 months of age, with the Arctic (E693G) and Swedish (K670N, M671L) mutations (tgArcSwe) of human APP were reared ad libitum at the animal facility at Uppsala University under a 12/12-hlight/dark cycle.
The animals were anesthetized with isoflurane and killed by decapitation. The brains were dissected quickly with 3 min postmortem delay and frozen on dry ice. All animal procedures were approved by an ethical committee and performed in compliance with national and local animal care and use guidelines (DNr #C17⁄ 14 at Uppsala University). Frozen tissue sections (12 µm thick) were cut in a cryostat microtome (Leica CM 1520, Leica Biosystems, Nussloch, Germany) at -18°C, and collected on special-coated, conducting glass slides (indium tin oxide, Bruker Daltonics, Bremen, Germany) and stored at -80°C. under vacuum for a period of ~20 minutes. The cooler was filled with ice slush (≥0 °C) for condensation of the matrix on the sample slides. The process was halted by removing the sublimation apparatus from the sand bath and closing the vacuum valve. The sublimation apparatus was allowed to slowly re-equilibrate to atmospheric pressure before removal of the sample plate. The amount of deposited matrix on ITO glass was determined using a highprecision scale (AX224, Sartorius, Göttingen, Germany) weighing the amount before and after the sublimation experiments. The sublimation protocol was optimized with respect to temperature, deposition time and total amount of deposited matrix to obtain the best detection efficiency for lipids on mouse brain tissue. With this setup, the optimum matrix layer was found to be 120µg/cm 2 to give the best lipid signals. We used optimized sublimation conditions: 20 minutes at a temperature of 130°C under a stable vacuum of 0.8 mbar. Prior to protein analysis, tissue sections were washed 2x 100% ethanol (EtOH) (30s) to get rid of the remaining 1,5-DAN matrix molecules on the tissue surface. Lipids and salts on the tissue surface were washed away in sequential washes of 70% EtOH (30s), 100% EtOH (30s), Carnoy's fluid (6:3:1 EtOH:chloroform:acetic acid) (2min), 100% EtOH (30s), H2O with 0.2% TFA (30s), and 100% EtOH (30s). 34 For teaching of the navigation points we used the same sharped-edged cross points created with the glass cutter pen prior to lipid analysis to minimize the repositioning error between lipid and protein imaging analysis. For protein MALDI-IMS, 2,5dihydroxyacetophenone (2,5-DHA) matrix compound was applied using a TM Sprayer (HTX Technologies, Carrboro, NC, USA) combined with a HPLC pump (Dionex P-580, Sunnyvale, CA, USA). Before every spraying experiment, the corresponding pump valve was cleaned from big bubbles using a syringe and ~10 minutes purge was applied to get rid of the little bubbles.
Sample Preparation and Matrix Application
Then the pump was kept running at 100µl/min using a 70% ACN pushing solvent with isocratic pressure for 3 hours. 15mg/ml 2,5-DHA in 60% ACN/1%CH3COOH/1%TFA solution was sprayed over the tissue sections using instrumental parameters including nitrogen flow of 10 psi, spray temperature of 75°C, nozzle height of 40mm, 8 passes with offsets and rotations, a spray velocity of 1300 mm/min. These parameters were optimized to avoid analyte delocalization on the tissue surface, while keeping the optimum incorporation of matrix and analyte molecules for an efficient desorption/ionization.
MALDI-IMS Analysis.
Imaging MS analysis of tissue sections was performed on a MALDI-TOF/TOF UltrafleXtreme mass spectrometer equipped with SmartBeam II Nd:YAG/355 nm laser operating at 1 kHz providing a laser spot diameter down to ~10µm for the 'minimum' focus setting (Bruker Daltonics). Measuring the absolute laser pulse energy of a smartbeam II laser is challenging in UltrafleXtreme systems, as such a measurement would require a reference measurement inside the instrument, which would require modification of the instrument hardware. Moreover, SmartBeam lasers do not have a flat-top shaped beam energy profile, but a rather highly structured beam energy profile, which makes it a hard task to measure the exact value of laser fluence at a flat target surface. 35 Therefore, rather than measuring the laser pulse energy, we provide detailed information about the laser pulse energy settings as previously indicated for lipid analysis in our previous communication; 30 global laser attenuator setting was kept stable at 10% throughout all the experiments and the laser focus set to minimum for 10µm and small for 30µm spatial resolution analysis. Attenuator offset and attenuator range settings were 40% and 10% for all the analysis. As SmartBeam II lasers lose some energy output over lifetime, it is necessary to specify the laser shot count of the instrument unit used for this experimentation, which was about 225696k (in ~12 months age). Identification of amyloid β plaque-associated lipids and Aβ1-40 m/z 4257.6 was achieved by examining MS/MS spectra obtained in LIFT-TOF/TOF mode as previously described. 29, 31 MALDI-LIFT (MS/MS) spectra were collected directly from plaque deposits in LIFT mode until a satisfactory convolution of fragment spectra was achieved. Lipid classifications were determined by comparing mass accuracy data and fragment spectra with the LIPID MAPS database (Nature Lipidomics Gateway, www.lipidmaps.org) and previous results obtained on tgArcSwe brain tissue sections for the lipid species have already been reported. 29, 31 
RESULTS AND DISCUSSION
High-Resolution, Dual Polarity MALDI-IMS: Enhanced Hippocampal Lipid Spectral
Quality and Spatial Molecular Information
High resolution MALDI-IMS is a strong approach to interrogate the spatial distribution profiles of biological molecules associated with spatially-confined histopathological features in neuroscience. 30,34,36 1,5-DAN was previously demonstrated to be a highly efficient MALDI matrix via sublimation matrix coating for brain lipids in both negative and positive polarities compared to several commonly used matrix compounds. 36 It is also reported that 1,5-DAN
gives enhanced spectral quality of brain lipid species in a wide spectral range with few number of low-energy laser pulses at high spatial resolutions. 30 Furthermore, ion signals are distinctly diverse and intense in negative polarity compared to positive polarity 30, 36 which can be attributed to distinct reductive properties and radical ion transfer abilities of 1,5-DAN 37 With respect to enhanced correlated lipidome analysis using 1,5-DAN sublimation MALDI-IMS approach, it was also demonstrated that dual polarity lipid analysis can be performed on the same pixel points at high spatial resolutions. 31 Here, this approach was utilized to reveal a comprehensive lipidome of hippocampus region of tgArcSwe mice brain ( Figure 1 ). Due to the limitations of the speed of data acquisition in UltrafleXtreme MALDI-TOF/TOF instruments at high spatial resolutions which is restricted by the vacuum stability of 1,5-DAN matrix molecule 36 , experiments were performed on the hippocampal areas of tgArcSwe coronal brain tissue sections where extensive amyloid plaque aggregates were revealed by previous amyloid specific IHC staining and/or MALDI-IMS studies. 29, 33, 38 Enhanced ionization at highspatial resolutions using low-energy few number of laser shots along with the minimized matrixderived signals revealed a high throughput hippocampal lipid spectral quality in transgenic AD mice (tgArcSwe) brain tissue in both polarities and on the same pixel points (Figure1).
In negative ionization mode, matrix related signals were minimized down to 320 Da. This yielded an enhanced low-molecular weight lipid signals (320-620 Da) otherwise would be suppressed and/or interfered by matrix-derived signals 30 Figure 1Ib ). In positive ion mode, matrix related signals were minimized down to 420 Da. This allowed us to observe low-molecular weight lysophosphatidylcholines, otherwise would be suppressed and/or interfered by matrix-derived signals 30 (Figure 1IIa ). Moreover, intense phospholipid signals, mainly phosphatidylcholines, were observed in the mass range of 650-900 Da along with the dimer peaks of phospholipids (1400-1700 Da) as previously observed in MALDI-TOF-MS 39 (Figure 1IIa (Figure 1IIb ), which can be simultaneously correlated with ion images obtained in negative polarity on the same pixel points (Figure 1Ib ). On the other hand, enhanced ionization of lipid species at high-spatial resolutions allowed us to observe pathological lipid changes not only brain region-specific but also directly correlated to the plaque aggregates ( Figure 2 ), whose amyloid β identities were demonstrated by subsequent peptide imaging on the same imaging sequence in hippocampus of tgArcSwe 
Amyloid Plaque Identification by Subsequent High-resolution Peptide MALDI-IMS on the
Same Tissue Section
1,5-DAN via sublimation allows enhanced ionization of lipid species without the need of high laser pulse energies. 30 This ''gentle'' MALDI-IMS methodology preserves the tissue morphology by minimizing the thermal and mechanical nanosecond laser ablation effects during the laser desorption/ionization process 30 and therefore allows successful fluorescent immunohistochemistry 30 or peptide/protein MALDI-IMS 31 on the same tissue section. In order to demonstrate the amyloid identity of lipid aggregates in the same hippocampal regions, subsequent MALDI-IMS was applied for peptide/protein analysis on the same tissue section.
This approach was demonstrated to be an alternative and superior strategy to previously applied amyloid specific immunohistochemistry and fluorescent staining experiments as it allows correlation of multiple Aβ isoform ion images with lipid ion images in dual polarity. 31 Therefore, we employed tri-modal MALDI-IMS paradigm for negative-and positive ion mode plaques, whereas the correlation was not conclusive at 30μm spatial resolution (Figure 3a) .
These results are potentially important as this high spatial resolution method allows correlation of tri-modal ion images to not only brain regions but also to individual plaque features which are spatially well-resolved ( Figure 3b ). 
Amyloid Plaque-Associated Alterations of Lipids in tgArcSwe Mice Brain Revealed by
Multimodal MALDI-IMS: Insights into the Molecular Pathology
Amyloid plaque formation is a dynamic process which was regulated by several enigmatic biochemical and biophysical processes. Most of the lipid classes were shown to be crucial players in AD pathogenesis including amyloid plaque pathology. 8, 15 Based on the published studies, one could have in view following main mechanisms for the action of lipids in amyloid pathology and senile plaque formation: Firstly, the interaction of amyloid peptides and/or amyloid oligomers with the cellular membranes effecting the membrane lipid homeostasis and/or effecting the organization and physicochemical properties of the membrane bilayer which alters APP processing. 11, 40 Secondly, the functional roles of peptides/proteins such as Aβ and APP Intracellular domain (AICD) in the regulation of lipid metabolism pathways either directly or by effecting the gene expressions encoding for APP, BACE1, the Aβ-degrading protease neriplysin (NEP) as well as several enzymes involved in lipid metabolism. 15, [41] [42] [43] [44] [45] Bidirectionally, lipid-peptide/protein interactions, whereby changes in lipids modulate the function of target proteins such as APP and APP-cleaving secretases. 46, 47 Finally, catalyzer and/or interfacial role of lipids in amyloid oligomerization and fibrillization. 12, 48, 49 Considering the heterogeneity of lipid molecules and complex bidirectional link between lipids and amyloid pathology, it is expectative to observe amyloid plaque-associated alterations of several lipid classes in tgArcSwe mice brain tissue. Here, high-resolution, highthroughput MALDI-IMS reveals a number of amyloid plaque-associated alterations of lipids including sphingolipids, phospholipids and lysophospholipids, which can give insights in to the molecular pathology of AD pathogenesis.
Sphingolipids including ceramides, sphingomyelins, and glycosphingolipids (GSLs) are major components of lipid rafts, playing a number of crucial parts in cell functions. 50 Growing evidence indicating that the amyloidogenic processing of APP occurs in lipid rafts 9 closely links sphingolipids to amyloid pathology. Moreover, the APP-processing product AICD downregulates the gene expression encoding for serine palmitoyl-CoA (SPT) enzyme which initiates the sphingolipid biosynthesis. 42 In addition, a number of studies have been reported on the alterations of sphingolipids in post-mortem human AD and transgenic AD mice brain tissue and their potential to modulate APP processing and Aβ aggregation. 51, 52 High-spatial resolution MALDI-IMS was performed on a hippocampal and adjacent cortical regions of a coronal tgArcSwe mice brain tissue section (Figure 4 Amyloid plaque-associated alterations of certain sphingolipids were previously described for the same transgenic mice (tgArcSwe) using MALDI-IMS and subsequent IHC and fluorescent staining on the same tissue section. 29 Here, high spatial-resolution multimodal MALDI-IMS reveals amyloid-plaque associaited alterations of several sphingolipid species all correlated to multiple Aβ isoforms at 10µm spatial resolution (Figure 4 ). Previously, shotgun lipidomics consistently revealed substantial decrease of sufatides and large content increase of ceramides in post-mortem human AD brain extracts relative to cognitively normal age-matched controls. 18 Our data indicates both hydroxylated and non-hydroxylated sulfatides, irrespective of their fatty acid (FA) moeity, depletes on the amyloid plaques (Figure 4e Further, elevation of ceramides (Cer 14:0, Cer 18:0) were correlated with the depletion of all the sulfatides (Figure 4n ) and all together correlated to amyloid isoforms (Figure 4m, 4p) . On the other hand, ceramide phosphates (CerP 18:0, m/z 644.6) showed an inconsistent plaqueassociated distribution. They were elevated in the cores and depleted on the edges of certain plaques (Figure 2b, Figure 4d ), which might be attributed to the structural heterogeneity and therefore the distinct molecular composition of amyloid plaques.
Sulfatides are one of the main consitutents of the myelin sheath surrounding axons in the CNS and mainly synthesized by oligodendrocytes playing key roles in the regulation of oligodendrocyte maturation and myelin formation. 53, 54 Ceramides are the central components in sphingolipid metabolism and serve as the backbones to generate sphingomyelin (SM) and
GSLs including sulfatides and gangliosides. Early reports indicated the role of apoE in both CNS and peripheral nervous system which is the regulation of sulfatide level. 55 Further, it has been hypothesized that the alterations of APOE ε4 allele-associated sphingolipid homeostasis through lipoprotein pathways can lead the depletion of sulfatides in myelin sheaths. 56, 57 On the other hand, the ceramide elevation in AD was suggested to be a possible degradation product of sulfatides 18 , but other explanations include Aβ induced membrane oxidative stress 58 , Aβmediated activation of sphingomyelinases (SMases) catalyzing the breakdown of SM to ceramide 59, 60 , and multiple gene expression abnormalities such as increased cerebral expression of genes involved in ceramide de novo synthesis along with the reduced expression of genes reguired for glycosphingolipid synthesis out of ceramide. 61 Our data suggest both sulfatide depletion and ceramide elevation are amyloid plaque-associated phenomena in tgArcSwe AD mice pathology (Figure 4m,n,p) . Indeed, an earlier study performed by quantitative fluorescent staining revealed amyloid plaque-associated demyelination and oligodendrocyte loss in both human and transgenic mice AD-brain. 62 Therefore, substantial amyloid plaque-associated depletion of sulfatides could reinforce the the previous results indicating amyloid plaques could be associated with regression of myelination which is another pathological hallmark AD.
Along with sulfatide depletion and ceramide elevation, substantial accumulation of gangliosides (GM3 18:0, GM3 20:0, GM2 18:0) were revealed on the same amyloid plaques ( Figure 4j-l, o) . Most earlier studies indicated a general reduction of gangliosides [63] [64] [65] along with the elevation of simpler gangliosides (GM2, GM3) 65, 66 in both transgenic mice and human AD brain extracts, which was hypothesized to be a result of accelerated lysosomal degradation and/or astrogliosis during neuronal cell death. 66 This in line with the reported accumulations of GM2 and GM3 in lysosomal storage disorders. 67, 68 Phospholipids are essential constituents of neuronal membranes providing structural integrity and functional properties. 69 Moreover, lysophospholipids, metabolic intermediates of phospholipid metabolism 70 interact with the lipid and protein moieties of neural membranes and modulate the function of neural membrane proteins, such as enzymes and growth factors. 71 Along with the sphingolipids, alterations in the levels of phospholipids, lysophospholipids along with the phospholipid-metabolizing enzymes such as PLA2, PLC, and PLD were reported in post-mortem human and trangenic AD mice brain tissues. [72] [73] [74] [75] Despite the high abundance and the efficient ionization of many of them, the structural diversity of phospholipids and lysophospholipids limit their comprehensive screening within a single MALDI-IMS analysis. Therefore, subsequent dual polarity lipid MALDI-IMS on the same tissue section increases the number of detected lipid species which can be correlated to spatial histopathological features. 31, 36, 76 Here, high spatial resolution, dual polarity analysis on the hippocampus of tgArcSwe mice brain tissue allowed us to simultaneously correlate the alterations of phospholipid ( Figure 5 ) and lysophospholipid ( Figure 6 Early reports generally indicated reductions of PE-PLs, PC-PLs and PI-PLs in human postmortem and transgenic AD-brains 17, 72, 77, 78 which was speculated to be due to the increased oxidative stress and stimulated activity of phospholipases in the presence of Aβ peptides resulting in PL degradation. 75, 79, 80 Figure   5j ,k,l). While this can be due to the pathogenesis difference between human and transgenic mice AD-brains, our results represents the alterations of this species in spatially confined amyloid plaques. AD-associated reduction of phosphatidylinositol kinase activity and depletion of phosphoinositide species in human AD-brain tissue were previously reported. 72, 84 Furthermore, oligomeric Aβ peptide was demonstrated to hinder phosphatidylinositol-4,5biphosphate levels in neurons. 11 Therefore, elevation of phosphatidylinositols on amyloid plaques might be associated with disruption of phosphoinositide formation pathways. Elevation of LPC species were previously demonstrated in the brains of 9 month-old transgenic AD mice (5XFAD) using MALDI-IMS. 75 Further, immunostaining of amyloid peptides and PLA2 indicated an extensive accumulation of amyloid peoptides in the cortex and subiculum along with the partial accumulation of PLA2 around the Aβ plaques. 75 Therefore, this suggest an amyloid plaque-associated hyperactivity of PLA2 which can result in the accumulation of lysophospholipids. 85 Our high spatial resolution reveals that lysophospholipid accumulation is amyloid plaque-associated phenomenon in tgArcSwe AD mice pathology which might be explained by the stimulated activity of phospholipases around amyloid plaques. In summary, we have applied a multimodal MALDI-IMS method to reveal highthroughput molecular information on amyloid plaques at high spatial resolutions in 18 month-old transgenic (tgArcSwe) AD mouse brains. Inspection of ion images revealed plaque-associated accumulation of amyloid peptides isoforms and neuronal lipids at high spatial resolutions. Dual polarity MALDI-IMS analysis of lipids revealed high troughput lipid molecular information which can be correlated to individual amyloid plaques at 10um spatial resolution. Here, we were, for the first time, able to correlate amyloid plaque-associate alterations of several sphingolipids, phospholipids and lysophospholipids to individual plaque features and certain amyloid peptide isoforms on the same tissue section. In conclusion, this methodology substantially increased the spatial amyloid plaque-associated molecular information. Insights into the possible pathways for the plaque-associated alterations of lipids were discussed.
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